September 24, 2012 — The European Medicines Agency (EMA) has recommended approval of the first enzyme-based debriding agent (NexoBrid, MediWound Ltd) to remove eschar from second- and third-degree ...
THE introduction of a satisfactory chemical method for the early débridement of burns would simplify a perplexing problem. For many years attempts have been made to find some agent that would ...
Enzymatic debridement employs proteolytic enzymes to selectively remove necrotic tissue (eschar) from burn wounds while preserving viable dermis. Historically derived from plant proteases such as ...
Please provide your email address to receive an email when new articles are posted on . Complete debridement was achieved by 63% of patients treated with EscharEx vs. 30.2% and 13.3% of comparison ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results